Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ) shot up at $0.34, a gain of 30%. On Tue, Mar 22, 2022, DFFN:NASDAQ hit a New 2-Week Intraday High of $0.27. The stock appeared on our News Catalysts scanner on Wed, Mar 23, 2022 at 04:48 PM in the 'MISCELLANEOUS' category. From Tue, Mar 08, 2022, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Thu, Mar 03, 2022 at $0.29 with a volume of 1M+.
About Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ)
Diffusion Pharmaceuticals Inc is a clinical stage biotechnology company focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy.
Top 10 Gainers:
- XORTX Therapeutics Inc. (XRTX:NASDAQ), 43.8%
- Imperial Petroleum Inc. (IMPP:NASDAQ), 37.25%
- Miromatrix Medical Inc. (MIRO:NASDAQ), 35.92%
- Four Seasons Education (Cayman) Inc. (FEDU:NYSE), 35.4%
- Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ), 29.98%
- 4D pharma plc (LBPS:NASDAQ), 28.48%
- Elite Education Group International Ltd. (EEIQ:NASDAQ), 27.36%
- Zentek Ltd. (ZTEK:NASDAQ), 25.93%
- Enveric Biosciences Inc. (ENVB:NASDAQ), 24.37%
- Femasys Inc. (FEMY:NASDAQ), 24.34%